Skip to main content
Medicon Hellas S.A. logo

Medicon Hellas S.A. — Investor Relations & Filings

Ticker · MEDIC ISIN · GRS424003002 LEI · 21380029I4NIQ9ZXE146 AT Manufacturing
Open in API
Filings indexed 7 across all filing types
Latest filing 2026-04-30 Interim / Quarterly Rep…
Country GR Greece
Listing AT MEDIC

About Medicon Hellas S.A.

http://www.mediconsa.com/en

Medicon Hellas S.A. is a company specializing in the in-vitro diagnostics (IVD) sector. Its core activities encompass the research, development, and manufacturing of a wide range of IVD reagents, particularly for clinical chemistry. The company also imports, distributes, installs, and provides technical support for automated analytical systems used in public and private hospitals, clinics, and laboratories. In addition to its primary diagnostics business, Medicon Hellas offers diagnostic laboratory services on a contract basis and develops related software. A secondary business segment involves the production of cosmetics and body care products.

Recent filings

Filing Released Lang Actions
FINANCIAL RESULTS PRESS RELEASE / PRESENTATIONS
Interim / Quarterly Report Classification · 95% confidence The document is titled 'FINANCIAL RESULTS ANNOUNCEMENT' and contains detailed financial data including sales, EBITDA, profit after tax, equity, borrowings, and condensed consolidated statements of profit or loss and financial position for the years 2024 and 2025. The presence of comprehensive financial statements and analysis for a specific fiscal period indicates this is a financial report rather than a brief announcement or presentation. The document length is 4179 characters, which is relatively short but contains substantive financial data and analysis, consistent with an Interim / Quarterly Report rather than a full Annual Report (10-K). There is no indication that this is an announcement of a report publication or a certification. The detailed financial figures and comparative period data align with the definition of an Interim / Quarterly Report (IR). FY 2025
2026-04-30 English
Οικονομική έκθεση MEDICON ΕΛΛΑΣ A.E (2025,Ετήσιος ισολογισμός,Ενοποιημένη)-iXBRL
Annual Report (ESEF) Classification · 100% confidence FY 2025
2026-04-30 Greek (modern)
Οικονομική έκθεση MEDICON ΕΛΛΑΣ A.E (2025,Εξαμηνιαία,Ενοποιημένη)
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive 'Half-Yearly Financial Report' (ΕΞΑΜΗΝΙΑΙΑ ΟΙΚΟΝΟΜΙΚΗ ΕΚΘΕΣΗ) for the period ending 30/6/2025. It includes the Board of Directors' management report, financial statements (consolidated and individual), and notes to the financial statements, as required by law (Law 3556/2007). It is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. H1 2025
2025-09-29 Greek (modern)
ΟΡΘΗ ΕΠΑΝΑΛΗΨΗ-ΓΝΩΣΤΟΠΟΙΗΣΗ ΑΠΟΚΟΠΗΣ ΔΙΚΑΙΩΜΑΤΟΣ ΜΕΡΙΣΜΑΤΟΣ / ΠΛΗΡΩΜΗΣ ΜΕΡΙΣΜΑΤΟΣ/ ΠΡΟΜΕΡΙΣΜΑΤΟΣ
Notice of Dividend Amount Classification · 99% confidence The document is titled "ΕΝΗΜΕΡΩΣΗ ΕΠΕΝΔΥΤΙΚΟΥ ΚΟΙΝΟΥ ΠΕΡΙ ΔΙΑΝΟΜΗΣ ΜΕΡΙΣΜΑΤΟΣ ΧΡΗΣΗΣ 2024" (Information to the Investment Community Regarding the Distribution of Dividend for the Fiscal Year 2024). It explicitly details the decision by the General Assembly to distribute a dividend, specifies the gross and net amounts per share (0.13 EUR gross, 0.123 EUR net), sets the ex-dividend date (July 7, 2025), and the payment start date (July 11, 2025). This content directly corresponds to the definition of a Notice of Dividend Amount.
2025-06-26 Greek (modern)
ΟΡΘΗ ΕΠΑΝΑΛΗΨΗ-ΑΝΑΚΟΙΝΩΣΗ ΓΙΑ ΤΙΣ ΑΠΟΦΑΣΕΙΣ ΓΕΝΙΚΗΣ ΣΥΝΕΛΕΥΣΗΣ
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "ΑΝΑΚΟΙΝΩΣΗ ΑΠΟΤΕΛΕΣΜΑΤΩΝ ΨΗΦΟΦΟΡΙΑΣ ΤΗΣ ΕΤΗΣΙΑΣ ΤΑΚΤΙΚΗΣ ΓΕΝΙΚΗΣ ΣΥΝΕΛΕΥΣΗ ΤΩΝ ΜΕΤΟΧΩΝ" (Announcement of Voting Results of the Annual General Meeting of Shareholders). It details the voting results on various agenda items discussed during the Annual General Meeting (AGM) held on June 25, 2025. Key items include the approval of 2024 financial statements, dividend distribution, approval of management compensation, and election of auditors. This content directly corresponds to the reporting of official results from a general meeting of shareholders. Therefore, the most appropriate classification is Declaration of Voting Results & Voting Rights Announcements (DVA).
2025-06-26 Greek (modern)
ΑΝΑΚΟΙΝΩΣΗ ΓΙΑ ΤΙΣ ΑΠΟΦΑΣΕΙΣ ΓΕΝΙΚΗΣ ΣΥΝΕΛΕΥΣΗΣ
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "ΑΝΑΚΟΙΝΩΣΗ ΑΠΟΤΕΛΕΣΜΑΤΩΝ ΨΗΦΟΦΟΡΙΑΣ ΤΗΣ ΕΤΗΣΙΑΣ ΤΑΚΤΙΚΗΣ ΓΕΝΙΚΗΣ ΣΥΝΕΛΕΥΣΗ ΤΩΝ ΜΕΤΟΧΩΝ" (Announcement of Voting Results of the Annual General Meeting of Shareholders) and details the voting outcomes on various agenda items (financial statements approval, dividend distribution, management approval, auditor election, etc.) that took place on June 25, 2025. This content directly corresponds to the official results of a shareholder vote following a General Meeting. The most specific category for official results from shareholder votes at any general meeting is 'Declaration of Voting Results & Voting Rights Announcements' (DVA). Although it relates to the AGM, the core content is the voting result declaration, not the AGM presentation materials (AGM-R) or the proxy solicitation materials (PSI).
2025-06-25 Greek (modern)

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.